3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one

C15H20N4O3 — CID 56707438

IUPAC3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one
SMILESO=C1CCC2(CCN1)CCN(C(=O)c1c[nH]c(=O)cn1)CC2
InChIInChI=1S/C15H20N4O3/c20-12-1-2-15(3-6-16-12)4-7-19(8-5-15)14(22)11-9-18-13(21)10-17-11/h9-10H,1-8H2,(H,16,20)(H,18,21)
InChIKeyMPUCYNDNBPAEHU-UHFFFAOYSA-N
MW304.35 g/mol
LogP0.29
Rot. Bonds1

About 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one

3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one (PubChem CID 56707438) has the molecular formula C15H20N4O3 and a molecular weight of 304.35 g/mol. Its IUPAC name is 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one.

Molecular Properties

Compound Name3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one
PubChem CID56707438
Molecular FormulaC15H20N4O3
Molecular Weight304.35 g/mol
Exact Mass304.15
IUPAC Name3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one
SMILESO=C1CCC2(CCN1)CCN(C(=O)c1c[nH]c(=O)cn1)CC2
InChIInChI=1S/C15H20N4O3/c20-12-1-2-15(3-6-16-12)4-7-19(8-5-15)14(22)11-9-18-13(21)10-17-11/h9-10H,1-8H2,(H,16,20)(H,18,21)
InChIKeyMPUCYNDNBPAEHU-UHFFFAOYSA-N
XLogP0.29
TPSA95.16 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds1
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500304.35
LogP ≤ 50.29
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[(2S)-2-butyl-4-methyl-3-oxopiperazine-1-carbonyl]-1H-pyrazin-2-one
CID 96397909
N-(2-aminoethyl)-1-(6-oxo-1H-pyrazine-3-carbonyl)piperidine-3-carboxamide
CID 63252199
6-oxo-N-(2-piperidin-3-ylethyl)-1H-pyrazine-3-carboxamide
CID 63627861
5-[2-(aminomethyl)-3-methylpiperidine-1-carbonyl]-1H-pyrazin-2-one
CID 64022064
5-[3-(2-aminoethyl)piperidine-1-carbonyl]-1H-pyrazin-2-one
CID 64027933
8-(6-oxo-1H-pyrazine-3-carbonyl)-2,8-diazaspiro[4.5]decan-3-one
CID 65967062
8-[(5-Hydroxy-2-pyrazinyl)carbonyl]-2-(3-methylbutyl)-2,8-diazaspiro[5.5]undecan-3-one
CID 70718863
3-Butyl-4-[(5-hydroxy-2-pyrazinyl)carbonyl]-1-methyl-2-piperazinone
CID 70751120
2-Butyl-8-[(5-hydroxy-2-pyrazinyl)carbonyl]-2,8-diazaspiro[5.5]undecan-3-one
CID 70774020
4-[(5-Hydroxy-2-pyrazinyl)carbonyl]-1-methyl-1,4,9-triazaspiro[5.6]dodecan-10-one
CID 72837239
5-({4-[3-(4-Ethylpiperazin-1-yl)-3-oxopropyl]piperidin-1-yl}carbonyl)pyrazin-2-ol
CID 72844043
9-Allyl-4-[(5-hydroxy-2-pyrazinyl)carbonyl]-1-methyl-1,4,9-triazaspiro[5.6]dodecan-10-one
CID 72880731

Frequently Asked Questions

What is the IUPAC name of 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one?
The IUPAC name of 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one (CID 56707438) is 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one.
What is the SMILES notation for 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one?
The canonical SMILES for 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one is O=C1CCC2(CCN1)CCN(C(=O)c1c[nH]c(=O)cn1)CC2.
What is the InChIKey of 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one?
The InChIKey is MPUCYNDNBPAEHU-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H20N4O3/c20-12-1-2-15(3-6-16-12)4-7-19(8-5-15)14(22)11-9-18-13(21)10-17-11/h9-10H,1-8H2,(H,16,20)(H,18,21).
What are the key properties of 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one?
3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one has a molecular weight of 304.35 g/mol, XLogP of 0.29, 1 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(6-oxo-1H-pyrazine-3-carbonyl)-3,10-diazaspiro[5.6]dodecan-9-one is sourced from PubChem (CID 56707438), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).